Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation

American Journal of Transplantation

Volumn 9, Issue 2, 2009, Pages 382-388

  Huurman, V A L ^a,d   Velthuis, J H L ^a,d   Hilbrands, R ^b,d   Tree, T I M ^c   Gillard, P ^b,d   Van Der Meer Prins, P M W ^a,d   Duinkerken, G ^a,d   Pinkse, G G M ^a,d   Keymeulen, B ^b,d   Roelen, D L ^a,d   Claas, F H J ^a,d   Pipeleers, D G ^b,d   Roep, B O ^a,d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d JDRF Center for Beta Cell Therapy in Diabetes   (Belgium)

Author keywords

Allograft monitoring; Allograft tolerance; Autoimmune diabetes; Cytokines; Islet transplantation; Mixed lymphocyte reaction

Indexed keywords

CYTOKINE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERLEUKIN 10; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ALLOIMMUNITY; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET TRANSPLANTATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH2 CELL;

COHORT STUDIES; CYTOKINES; DIABETES MELLITUS; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 58849105854     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02479.x     Document Type: Article

References (39)

1. Naftanel MA, Harlan DM. Pancreatic islet transplantation. PLoS Med 2004 1 : e58.
2. Gaglia JL, Shapiro AM, Weir GC. Islet transplantation: Progress and challenge. Arch Med Res 2005 36 : 273 280.
3. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000 343 : 230 238.
4. Ryan EA, Paty BW, Senior PA et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005 54 : 2060 2069.
5. Ricordi C, Inverardi L, Kenyon NS, Goss J, Bertuzzi F, Alejandro R. Requirements for success in clinical islet transplantation. Transplantation 2005 79 : 1298 1300.
6. Keymeulen B, Gillard P, Mathieu C et al. Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft. Proc Natl Acad Sci USA 2006 103 : 17444 17449.
7. Emamaullee JA, Shapiro AM. Interventional strategies to prevent beta-cell apoptosis in islet transplantation. Diabetes 2006 55 : 1907 1914.
8. Fiorina P, Vergani A, Petrelli A et al. Metabolic and immunological features of the failing islet-transplanted patient. Diabetes Care 2008 31 : 436 438.
9. Jansson L, Carlsson PO. Graft vascular function after transplantation of pancreatic islets. Diabetologia 2002 45 : 749 763.
10. Tjernberg J, Ekdahl KN, Lambris JD, Korsgren O, Nilsson B. Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation. Transplantation 2008 85 : 1193 1199.
11. Monti P, Scirpoli M, Maffi P et al. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. J Clin Invest 2008 118 : 1806 1814.
12. Campbell PM, Salam A, Ryan EA et al. Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation. Am J Transplant 2007 7 : 1242 1248.
13. Shapiro AM, Ricordi C, Hering BJ et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006 355 : 1318 1330.
14. Huurman VA, Hilbrands R, Pinkse GG et al. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS ONE 2008 3 : e2435.
15. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 1993 14 : 203 208.
16. Roelen DL, van Bree FP, Schanz U, van Rood JJ, Claas FH. Differential inhibition of primed alloreactive CTLs in vitro by clinically used concentrations of cyclosporine and FK506. Transplantation 1993 56 : 190 195.
17. Van Der Mast BJ, van Besouw NM, de Kuiper P et al. Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression. Transplantation 2001 72 : 873 880.
18. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003 3 : 199 210.
19. Waldmann H, Adams E, Fairchild P, Cobbold S. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol Rev 2006 212 : 301 313.
20. Ling Z, Pipeleers DG. Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J Clin Invest 1996 98 : 2805 2812.
21. Keymeulen B, Ling Z, Gorus FK et al. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: Graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia 1998 41 : 452 459.
22. Maleux G, Gillard P, Keymeulen B et al. Feasibility, safety, and efficacy of percutaneous transhepatic injection of beta-cell grafts. J Vasc Interv Radiol 2005 16 : 1693 1697.
23. Bouma GJ, Van Der Meer-Prins PM, van Bree FP, van Rood JJ, Claas FH. Determination of cytotoxic T-lymphocyte precursor frequencies using europium labeling as a nonradioactive alternative to labeling with chromium-51. Hum Immunol 1992 35 : 85 92.
24. Strijbosch LW, Does RJ, Buurman WA. Computer aided design and evaluation of limiting and serial dilution experiments. Int J Biomed Comput 1988 23 : 279 290.
25. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 2005 54 : 92 99.
26. Van Den Boogaardt DE, van Miert PP, de Vaal YJ, de Fijter JW, Claas FH, Roelen DL. The ratio of interferon-gamma and interleukin-10 producing donor-specific cells as an in vitro monitoring tool for renal transplant patients. Transplantation 2006 82 : 844 848.
27. Van Der Meer A, Joosten I, Schattenberg AV, de Witte TJ, Allebes WA. Cytotoxic T-lymphocyte precursor frequency (CTLp-f) as a tool for distinguishing permissible from non-permissible class I mismatches in T-cell-depleted allogeneic bone marrow transplantation. Br J Haematol 2000 111 : 685 694.
28. van Besouw NM, Van Der Mast BJ, de Kuiper P et al. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. Transplantation 2000 70 : 136 143.
29. Dolezalova L, Vrana M, Dobrovolna M et al. Cytotoxic T lymphocyte precursor frequency analysis in the selection of HLA matched unrelated donors for hematopoietic stem cell transplantation: The correlation of CTLp frequency with HLA class I genotyping and aGVHD development. Neoplasma 2002 49 : 26 32.
30. Salama AD, Najafian N, Clarkson MR, Harmon WE, Sayegh MH. Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 2003 14 : 1643 1651.
31. Meloni F, Vitulo P, Bianco AM et al. Regulatory CD4+CD25 +T cells in the peripheral blood of lung transplant recipients: Correlation with transplant outcome. Transplantation 2004 77 : 762 766.
32. Weston LE, Geczy AF, Briscoe H. Production of IL-10 by alloreactive sibling donor cells and its influence on the development of acute GVHD. Bone Marrow Transplant 2006 37 : 207 212.
33. Moore KW, de Waal MR, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001 19 : 683 765.
34. Arif S, Tree TI, Astill TP et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 2004 113 : 451 463.
35. Battaglia M, Stabilini A, Draghici E et al. Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes 2006 55 : 1571 1580.
36. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006 212 : 28 50.
37. Clarkson MR, Sayegh MH. T-cell costimulatory pathways in allograft rejection and tolerance. Transplantation 2005 80 : 555 563.
38. Hainz U, Jurgens B, Heitger A. The role of indoleamine 2,3-dioxygenase in transplantation. Transpl Int 2007 20 : 118 127.
39. Salama AD, Womer KL, Sayegh MH. Clinical transplantation tolerance: Many rivers to cross. J Immunol 2007 178 : 5419 5423.